SynaptixBio

Oxford biotech firm secures £13.2m to develop first treatment for rare, incurable, deadly disease.

A pioneering biotech firm has secured £13.2 million to fund its mission to develop the world’s first treatment for a rare, incurable and...

200 views

British biotech firm secures FDA rare paediatric disease designation

British biotech firm secures FDA rare paediatric disease designation in bid to develop world’s first treatment for incurable, deadly disease

130 views

Children with undiagnosed conditions urged to get checked for rare, incurable and deadly disease

36 views

We were delighted to welcome Sky News to Oxfordshire in November

25 views

The powerful story of Frankie Sheridan-Hill, aged seven, featured on ITV

12 views

SynaptixBio agrees US children’s hospital deal to develop world’s first treatment for deadly disease

Biotech firm enters into a pioneering new licence agreement in bid to develop world’s first treatment for deadly disease

84 views

‘Time running out’ in teen girl’s battle with TUBB4a leukodystrophy

74 views

Thousands of patients could have rare life-threatening diseases without knowing it, experts warn

Thousands of patients could unknowingly suffer with a rare life-threatening disease, experts have warned. TUBB4a leukodystrophy - an...

1 view

Mum diagnoses daughter's rare life-threatening disease

14 views

New biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseases

New biotech firm launched to develop ‘revolutionary’ new treatment for one of world’s rarest neurodegenerative diseases

52 views